PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Funding for orthobiologics development • Orthobiologic products under clinical trial PART 06: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 07: Market segmentation by product • Global orthobiologics market by stem cells • Global orthobiologics market by bone morphogenetic proteins • Global orthobiologics market by synthetic bone grafts • Global orthobiologics market by viscosupplements • Global orthobiologics market by demineralized bone matrix • Global orthobiologics market by allografts PART 08: Market segmentation by procedure • Spinal fusion surgery • Orthopedic trauma and reconstruction surgery PART 09: Geographical segmentation • Orthobiologics market in Americas • Orthobiologics market in EMEA • Orthobiologics market in APAC PART 10: Market drivers • Popularity of spinal fusion surgeries • Rise in strategic partnerships for marketing • Prevalence of arthritis PART 11: Impact of drivers PART 12: Market challenges • High cost of spinal fusion surgery • Product side effects and FDA scrutiny • Poor performance of bone graft substitute PART 13: Impact of drivers and challenges PART 14: Market trends • Funds to enhance orthobiologics • Product development in collaboration with research institutes • Increase in M&A PART 15: Vendor landscape • Competitive scenario • Market share analysis • DePuy Synthes • Medtronic • Sanofi • Stryker • Zimmer Biomet • Other prominent vendors PART 16: Appendix • List of abbreviations PART 17: Explore Technavio   List of Exhibits Exhibit 01: Product offerings 7 Exhibit 02: Funding for orthobiologics development Exhibit 03: Global orthobiologics market segmentation by product and procedure Exhibit 04: Global orthobiologics market 2015-2020 ($ billions) Exhibit 05: Five forces analysis Exhibit 06: Global orthobiologics market by product 2015 Exhibit 07: Global orthobiologics market by stem cells 2015-2020 ($ millions) Exhibit 08: Global orthobiologics market by bone morphogenetic proteins 2015-2020 ($ millions) Exhibit 09: Global orthobiologics market by synthetic bone grafts 2015-2020 ($ millions) Exhibit 10: Global orthobiologics market by viscosupplements 2015-2020 ($ billions) Exhibit 11: Global orthobiologics market by demineralized bone matrix 2015-2020 ($ millions) Exhibit 12: Global orthobiologics market by allografts 2015-2020 ($ millions) Exhibit 13: Global orthobiologics market by procedure 2015 Exhibit 14: Global orthobiologics market by geography 2015 Exhibit 15: Orthobiologics market in Americas 2015-2020 ($ billions) Exhibit 16: Orthobiologics market in EMEA 2015-2020 ($ billions) Exhibit 17: Orthobiologics market in APAC 2015-2020 ($ millions) Exhibit 18: Global orthobiologics market by geography 2015-2020 Exhibit 19: Impact of drivers Exhibit 20: Impact of drivers and challenges Exhibit 21: Ranking of vendors 2015 Exhibit 22: Competitive scenario of vendors 2015 Exhibit 23: Comparative analysis of vendors and their orthobiologic products Exhibit 24: Collaboration between vendors and universities or organizations Exhibit 25: DePuy Synthes: Key takeaways Exhibit 26: DePuy Synthes: Business segmentation Exhibit 27: Medtronic: Key takeaways Exhibit 28: Medtronic: Business segmentation by revenue 2015 Exhibit 29: Sanofi: Key takeaways Exhibit 30: Sanofi: Product revenue 2014 Exhibit 31: Sanofi: Product revenue comparison 2013 and 2014 ($ millions) Exhibit 32: Stryker: Key takeaways Exhibit 33: Stryker: Business segmentation by revenue 2014 Exhibit 34: Stryker: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 35: Stryker: Geographical segmentation by revenue 2014 Exhibit 36: Zimmer Biomet: Key takeaways Exhibit 37: Zimmer Biomet: Business segmentation by revenue 2014 Exhibit 38: Zimmer Biomet: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 39: Zimmer Biomet: Geographical segmentation by revenue 2014

DePuy Synthes, Medtronic, Sanofi, Stryker, Zimmer Biomet, Alphatec Spine, AlloSource, AMEDICA, Anika Therapeutics, Arthrex, Baxter, BBS-Bioactive Bone Substitutes Oy, Berkeley Advanced Biomaterial, Biomimetic Therapeutics, Bioventus, Bone Therapeutics, Ceramisys, Geistlich Bio-Oss, Graftys, Integra Life Sciences, ISTO Technologies, Keramat, NovaBone, Orthogem Limited, Orthofix International, OsteoMed, RTI Surgical, Sigma Graft, Smith & Nephew, Straumann, Wright Medical, Xtant Medical.